<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bone morphogenetic proteins (BMP) are part of the TGF-β-signaling pathway; genetic variation in these genes may be involved in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we evaluated the association between genetic variation in BMP1 (11 tagSNPs), BMP2 (5 tagSNPs), BMP4 (3 tagSNPs), BMPR1A (9 tagSNPs), BMPR1B (21 tagSNPs), BMPR2 (11 tagSNPs) and GDF10 (7 tagSNPs) with risk of colon and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> molecular phenotype </plain></SENT>
<SENT sid="2" pm="."><plain>We used data from population-based case-control studies (<z:hpo ids='HP_0003003'>colon cancer</z:hpo> n = 1,574 cases, 1,970 controls; <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> n = 791 cases, 999 controls) </plain></SENT>
<SENT sid="3" pm="."><plain>We observed that genetic variation in BMPR1A, BMPR1B, BMPR2, BMP2 and BMP4 was associated with risk of developing <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, with 20 to 30% increased risk for most high-risk genotypes </plain></SENT>
<SENT sid="4" pm="."><plain>A summary of high-risk genotypes showed over a twofold increase in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> risk at the upper risk category (OR = 2.49 95% CI = 1.95, 3.18) </plain></SENT>
<SENT sid="5" pm="."><plain>BMPR2, BMPR1B, BMP2 and GDF10 were associated with <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>BMPR2 rs2228545 was associated with an almost twofold increased risk of <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The risk associated with the highest category of the summary score for <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> was 2.97 (95% CI = 1.87, 4.72) </plain></SENT>
<SENT sid="8" pm="."><plain>Genes in the BMP-signaling pathway were consistently associated with CIMP+ status in combination with both KRAS-mutated and MSI <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>BMP genes interacted statistically significantly with other genes in the TGF-β-signaling pathway, including TGFβ1, TGFβR1, Smad 3, Smad 4 and Smad 7 </plain></SENT>
<SENT sid="10" pm="."><plain>Our data support a role for genetic variation in BMP-related genes in the etiology of colon and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>One possible mechanism is via the TGF-β-signaling pathway </plain></SENT>
</text></document>